Cannabis investors are a different breed. They’re amped way higher on positivity, cynicism, self belief, and sorrow, prone to the sort of mania that baseball card, Cabbage Patch Kid, and tulip enthusiasts know in their plums.
In the cannabis “Get-Big-Fast” era, where weed companies buy stuff (grow-ops, dispensaries, websites, manufacturing plants, brands etc.) and post gigantic quarterly losses, it’s refreshing to see one company do it the old-fashioned way.
Golden Leaf Holdings (GLH.C) received a 30% share price bump when their subsidiary, Medical Marijuana Group Corporation, got their medical processing and sale license from Health Canada today.
Khiron Life Sciences (KHRN.C) is the only Colombian cannabis company generating revenue from legal production. We checked.